logologo
Search anything
Ctrl+K
arrow

Stock Summary and Key Metrics













Investment Checklist




























Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Ask AI

mockupmockup

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

View Standalone

Total Figures
QoQ Changes
Total Figures
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales1,3051,2041,2791,3411,4001,3671,4751,5071,6442,151
Expenses9979259851,0371,0921,0601,1181,1701,2411,784
Operating Profit308279295304308307358337403367
OPM %23.6123.1823.0222.6622.0322.4624.2422.3524.4917.07
Other Income181824232418182323-30
Interest23252834353741454265
Depreciation556365626570838487122
Profit Before Tax248209226232232219253231295150
Tax %8.749.8215.4413.0314.2311.7722.4415.0712.5914.81
Net Profit227188191201199193196196258128
EPS in Rs11.169.269.399.929.789.509.719.6812.726.24

Consolidated Profit Loss (in ₹ Crores)

View Standalone

View Standalone

Total Figures
YoY Changes
Total Figures
Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales1,8782,2812,8613,1282,5833,7014,5255,0185,4835,749
Expenses1,6492,0692,5732,7052,4003,0483,5593,8664,2074,439
Operating Profit2292122884231836549661,1521,2761,310
OPM %12.199.3110.0613.527.0817.6621.3522.9623.2822.79
Other Income8.2115149.46212665758484
Interest2247718576666997146158
Depreciation80100137186184183210242278302
Profit Before Tax1358093161-56430752889936934
Tax %38.6936.0436.5326.1974.5120.4019.2911.1315.5816.09
Net Profit835159119-14342607790790784
EPS in Rs4.102.542.915.86-0.7116.8329.8638.8738.9138.35
Dividend Payout %0.000.0034.2517.060.005.948.3810.2911.57

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

View Standalone

Total Figures
YoY Changes
Total Figures
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital204204204204204204204204204204
Reserves6727598318779329161,2841,9272,6793,422
Borrowings2321897347378648267238841,6272,428
Other Liabilities4484957668198918249181,1471,1141,210
Total Liabilities1,5561,6472,5362,6372,8912,7703,1314,1625,6257,265
Fixed Assets1,0551,0821,8481,8382,0921,9611,9802,3362,6514,266
CWIP1453355612206725951486
Investments87968.7817861201322528441,084
Other Assets4014166447257016699511,3151,6151,829
Total Assets1,5561,6472,5362,6372,8912,7703,1314,1625,6257,265

Consolidated Cash Flows (in ₹ Crores)

View Standalone

View Standalone

Total Figures
YoY Changes
Total Figures
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity1742191822794433044851,0851,067986
Cash from Investing Activity-150-146-520-161-189-113-267-1,174-1,458-1,325
Cash from Financing Activity18-45315-27-247-194-15988488544
Net Cash Flow4228-23907.86-2.3659-1.8097205

Shareholdings

Shareholding History

Quarterly
Yearly
Quarterly
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters64.26%64.25%64.25%64.25%64.25%64.25%64.25%64.25%64.25%64.25%63.67%63.67%
FIIs11.18%11.67%11.58%10.98%10.07%9.74%9.50%9.72%10.52%10.55%11.17%10.04%
DIIs12.03%10.96%10.30%9.57%8.29%7.95%8.74%8.57%8.14%7.81%7.96%9.21%
Public12.54%13.13%13.87%15.20%17.40%18.06%17.51%17.46%17.09%17.39%17.20%17.08%
Total Shareholders86,6311,02,9941,20,5061,38,0521,60,6861,78,3561,77,7921,85,7872,05,6392,26,4802,28,1232,20,561

Market Transactions

professional

Unlock more with professional

  • Real-time bulk & block deal transactions
  • Export transaction data for analysis
transaction-premiumtransaction-premium

Documents

Presentations
Concalls
Reports
Presentations
iconiconicon

Investor Presentation

Q3 FY26

iconiconicon

Investor Presentation

Q2 FY26

iconiconicon

Investor Presentation

Q1 FY26

lock

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

iconiconicon

Investor Presentation

Q4 FY25

lock

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

iconiconicon

Investor Presentation

Q3 FY25

lock

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

iconiconicon

Investor Presentation

Q2 FY25

lock

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

iconiconicon

Investor Presentation

Q1 FY25

lock

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

iconiconicon

Investor Presentation

Q4 FY24

lock

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Showing 1 - 8 of 40

Actions

Action Type




























































AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Ask AI

ai-corner-premiumai-corner-premium
ai-corner-premiumai-corner-premium

Frequently Asked Questions about Narayana Hrudayalaya Ltd

Narayana Hrudayalaya Ltd (NH) is currently trading at 1,874.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Narayana Hrudayalaya Limited is a multi‑speciality and super‑speciality healthcare operator founded by Dr. Devi Prasad Shetty, running a network of hospitals, clinics and management‑run facilities across India and international markets including Cayman Islands and the UK, offering tertiary care, robotic procedures, oncology and cardiac services alongside integrated care and an insurance business. Recent quarters show meaningful margin expansion in the India portfolio driven by a multi‑year transformation: payor‑mix optimisation, higher‑realisation cases including robotic cardiac and bone marrow transplants, and technology infusion have driven 150–200 bps YoY margin improvement in the India business with management intent to sustain these gains where possible. The Group has accelerated international footprint via a material UK acquisition (Practice Plus) and continued Cayman investment; the UK deal was funded with substantial debt (GBP 150m) and equity (GBP 45m) and is expected to be EBITDA neutral to mildly accretive over time after integration and operational efficiencies, while creating short‑term ROCE normalization. Narayana is investing in an integrated care stack — clinics, pharmacies, and insurance (NHIC) — accepting near‑term losses to build distribution and cross‑sell; management is deliberately merging clinic operations into NHL and reporting insurance separately, with losses narrowing but breakeven timelines still uncertain as investments continue.

Over the past 52 weeks, Narayana Hrudayalaya Ltd has traded between a low of ₹1,564.25 and a high of ₹2,371.60. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Narayana Hrudayalaya Ltd has a market capitalization of approximately 38,589.45. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Narayana Hrudayalaya Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 49.54 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 38,589.45 Cr, Narayana Hrudayalaya Ltd is classified as a Mid Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Narayana Hrudayalaya Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Narayana Hrudayalaya Ltd is 49.54. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The stock price increased by 3% after the company announced the purchase of a 3.3-acre property in Bengaluru's Electronic City for business expansion, including setting up a Global Capability Center.

The meetings were held to seek approval from equity shareholders, secured creditors, and unsecured creditors for the proposed scheme of arrangement involving the demerger of NH Integrated Care Private Limited into Narayana Hrudayalaya Limited.

The main outcome was the overwhelming approval from shareholders and creditors for the scheme of arrangement involving the demerger with NH Integrated Care Private Limited.

The most significant positive is the proposed scheme to develop five regional medical hubs in partnership with the private sector, which will provide a major boost to the medical tourism segment, a key strength for Narayana Hrudayalaya.